$MAZE
Maze Therapeutics (MAZE) Insider Trading
Maze Therapeutics, Inc.Small Cap$1.9B
Maze Therapeutics insiders sold $25.0M in the last 12 months, mostly under preset 10b5-1 plans, led by Harold Bernstein, with no insider purchases.
View trades →
Insiders (12-Month)
6 Insiders
View trades →
Insider Buys (12-Month)
No insider buys
Latest Buy
No open-market buys on record
Politicians (12-Month)
No politician trades
Recent Insider Trades in MAZE
| Type | Insider | Role | Price | Shares | ΔOwn | Value | Filed |
|---|---|---|---|---|---|---|---|
SELL10b5-1 | Coloma Jason V | CEO | $30.25 | 34,501 | — | -$1,043,766 | 18h ago |
SELLOE+Sale10b5-1 | Dandekar Atul | Csbo | $32.07 | 7,500 | −18.8% | -$240,532 | Oct 30, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $26.93 | 16,141 | All | -$434,743 | Oct 2, '26 |
SELL10b5-1 | Coloma Jason V | CEO | $27.02 | 34,501 | −12.8% | -$932,260 | Oct 2, '26 |
SELLOE+Sale10b5-1 | Dandekar Atul | Csbo | $27.06 | 7,500 | −18.8% | -$202,921 | Oct 1, '26 |
SELL10b5-1 | Bernstein Harold | President, R&D & CMO | $26.22 | 9,705 | All | -$254,502 | Sep 8, '26 |
SELL | Courtney Phillips | GC & Corp. Secretary | $26.24 | 3,993 | −36.3% | -$104,766 | Sep 4, '26 |
SELL | Dandekar Atul | Csbo | $26.24 | 6,434 | −16.6% | -$168,811 | Sep 4, '26 |
SELL | Coloma Jason V | CEO | $26.24 | 22,638 | −7.8% | -$593,955 | Sep 4, '26 |
SELL | Bernstein Harold | President, R&D & CMO | $26.24 | 10,295 | −51.5% | -$270,111 | Sep 4, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $26.36 | 16,141 | −44.7% | -$425,512 | Sep 3, '26 |
SELLOE+Sale10b5-1 | Coloma Jason V | CEO | $26.29 | 34,501 | −10.6% | -$906,999 | Sep 3, '26 |
SELLOE+Sale10b5-1 | Dandekar Atul | Csbo | $27.58 | 7,500 | −22.2% | -$206,824 | Aug 31, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $27.61 | 16,142 | All | -$445,621 | Aug 14, '26 |
SELL | Coloma Jason V | CEO | $26.73 | 34,501 | −11.1% | -$922,315 | Aug 5, '26 |
SELLOE+Sale10b5-1 | Dandekar Atul | Csbo | $27.34 | 7,500 | −22.2% | -$205,031 | Jul 31, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $29.90 | 14,609 | All | -$436,864 | Jul 2, '26 |
SELL10b5-1 | Coloma Jason V | CEO | $29.98 | 34,501 | −10.0% | -$1,034,253 | Jul 2, '26 |
SELLOE+Sale10b5-1 | Dandekar Atul | Csbo | $28.02 | 7,500 | −22.2% | -$210,150 | Jul 1, '26 |
SELL10b5-1 | Coloma Jason V | CEO | $26.04 | 27,858 | −7.5% | -$725,495 | Jun 24, '26 |
SELL10b5-1 | Coloma Jason V | CEO | $26.20 | 6,643 | −1.8% | -$174,048 | Jun 3, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $25.66 | 14,853 | All | -$381,112 | Jun 3, '26 |
SELLOE+Sale10b5-1 | Dandekar Atul | Csbo | $26.34 | 7,500 | −23.2% | -$197,554 | Jun 2, '26 |
SELL10b5-1 | Coloma Jason V | CEO | $26.01 | 32,564 | −7.9% | -$847,048 | May 27, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $26.22 | 15,000 | All | -$393,354 | May 18, '26 |
SELL10b5-1 | Coloma Jason V | CEO | $26.00 | 1,938 | −0.5% | -$50,388 | May 18, '26 |
SELLOE+Sale10b5-1 | Dandekar Atul | Csbo | $25.37 | 7,500 | −41.7% | -$190,299 | May 1, '26 |
SELLOE+Sale10b5-1 | Bachrodt Amy | SVP, Finance | $29.44 | 2,500 | −16.2% | -$73,611 | Apr 2, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $29.46 | 15,000 | All | -$441,904 | Apr 2, '26 |
SELLOE+Sale10b5-1 | Dandekar Atul | Csbo | $29.34 | 7,500 | −41.7% | -$220,019 | Apr 1, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $49.10 | 15,000 | All | -$736,439 | Mar 20, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $50.45 | 30,000 | All | -$1,513,560 | Mar 12, '26 |
SELLOE+Sale10b5-1 | Dandekar Atul | Csbo | $45.43 | 7,500 | −41.7% | -$340,723 | Mar 3, '26 |
SELLOE+Sale10b5-1 | Bachrodt Amy | SVP, Finance | $45.20 | 5,000 | −27.8% | -$226,011 | Mar 3, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $46.02 | 15,000 | All | -$690,334 | Feb 4, '26 |
SELLOE+Sale10b5-1 | Bachrodt Amy | SVP, Finance | $46.04 | 5,000 | −27.8% | -$230,219 | Feb 4, '26 |
SELLOE+Sale10b5-1 | Dandekar Atul | Csbo | $44.27 | 7,500 | −41.7% | -$331,990 | Feb 2, '26 |
SELLOE+Sale | Bachrodt Amy | — | $45.52 | 5,000 | −27.8% | -$227,612 | Jan 26, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $40.20 | 25,156 | All | -$1,011,299 | Jan 9, '26 |
SELLOE+Sale | Sohn Catherine A. | Director | $39.07 | 29,413 | All | -$1,149,054 | Jan 8, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $40.39 | 4,844 | All | -$195,668 | Jan 6, '26 |
SELLOE+Sale10b5-1 | Bachrodt Amy | SVP, Finance | $39.15 | 5,000 | −27.8% | -$195,754 | Jan 6, '26 |
SELLOE+Sale10b5-1 | Bernstein Harold | President, R&D & CMO | $40.56 | 45,000 | All | -$1,825,355 | Dec 31, '25 |
SELLOE+Sale10b5-1 | Bachrodt Amy | SVP, Finance | $40.41 | 15,000 | −53.6% | -$606,173 | Dec 31, '25 |
SELLOE+Sale10b5-1 | Dandekar Atul | Csbo | $40.56 | 72,500 | −87.3% | -$2,940,799 | Dec 31, '25 |
Older than 12 months | |||||||
SELL | Scheller Richard H | Director | $22.37 | 20,744 | All | -$464,035 | Sep 16, '25 |